Australia markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.44-0.45 (-4.13%)
At close: 04:00PM EST
10.52 +0.08 (+0.77%)
After hours: 07:56PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,387,715
1,146,290
475,598
18,662
Operating expenses
Research development
1,940,385
2,534,508
747,027
113,842
Selling general and administrative
411,242
298,358
145,290
34,417
Total operating expenses
2,892,669
2,832,866
892,317
148,259
Operating income or loss
-1,225,828
-1,686,576
-416,719
-129,597
Interest expense
20,417
21,127
15,145
12,188
Total other income/expenses net
-52,568
-6,833
13,605
10,515
Income before tax
-1,298,813
-1,714,536
-418,259
-132,694
Income tax expense
23,161
29,215
-
-
Income from continuing operations
-1,321,974
-1,743,751
-418,259
-132,694
Net income
-1,321,974
-1,743,751
-418,259
-132,694
Net income available to common shareholders
-1,321,974
-1,743,751
-418,259
-132,694
Basic EPS
-
-23.44
-7.27
-5.51
Diluted EPS
-
-23.44
-7.27
-5.51
Basic average shares
-
74,400
57,554
24,100
Diluted average shares
-
74,400
57,554
24,100
EBITDA
-
-1,680,748
-398,229
-114,830